Moderna Inc
F:0QF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Moderna Inc
F:0QF
|
US |
|
C
|
Cardinal Health Inc
XMUN:CLH
|
US |
|
Caixabank SA
F:48CA
|
ES |
|
Red Violet Inc
NASDAQ:RDVT
|
US |
|
BioNTech SE
NASDAQ:BNTX
|
DE |
|
BOK Financial Corp
F:BJR
|
US |
|
H
|
Henry Schein Inc
XHAM:HS2
|
US |
|
N
|
Nikon Corp
DUS:NKN
|
JP |
|
A
|
Abbott Laboratories
F:ABL
|
US |
|
H
|
Helmerich and Payne Inc
XBER:HPC
|
US |
|
Cambricon Technologies Corp Ltd
SSE:688256
|
CN |
|
M
|
MGIC Investment Corp
XMUN:MGC
|
US |
|
V
|
Varonis Systems Inc
F:VS2
|
US |
|
I
|
Isetan Mitsukoshi Holdings Ltd
DUS:4HP
|
JP |
Wall St Price Targets
0QF Price Targets Summary
Moderna Inc
According to Wall Street analysts, the average 1-year price target for 0QF is 47.12 EUR with a low forecast of 21.66 EUR and a high forecast of 121.58 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0QF's stock price target?
Price Target
47.12
EUR
According to Wall Street analysts, the average 1-year price target for 0QF is 47.12 EUR with a low forecast of 21.66 EUR and a high forecast of 121.58 EUR.
What is the Revenue forecast for Moderna Inc?
Projected CAGR
19%
Over the last 8 years, the compound annual growth rate for Revenue has been 32%. The projected CAGR for the next 8 years is 19%.
What is the Gross Profit forecast for Moderna Inc?
Projected CAGR
20%
The compound annual growth rate for Gross Profit over the next 8 years is 20%.
